Abstract
摘要
相似文献
1
3TC and saquinavir: we need them now.
BETA. 1995 Sep:3.
2
Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert. 1996 Jan;11(1):1-4.
3
FDA triple header. Food and Drug Administration.
GMHC Treat Issues. 1995 Nov;9(11):1-3.
4
FDA approves 3TC and saquinavir. Food and Drug Administration.
BETA. 1995 Dec:5, 9.
5
Roche submits NDA for Invirase.
J Int Assoc Physicians AIDS Care. 1995 Sep;1(8):37-8.
6
New drugs for HIV infection.
Med Lett Drugs Ther. 1996 Apr 12;38(972):35-7.
7
Nipping HIV in the bud.
GMHC Treat Issues. 1996 Aug;10(8):3-6.
8
A kinder, gentler ddC... for $7,200 a year.
GMHC Treat Issues. 1995 Dec;9(12):2.
9
FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
AIDS Treat News. 1995 Oct 20(no 233):4-5.
10
Lamivudine (3TC) approved for combination use with AZT.
AIDS Treat News. 1995 Dec 1(no 236):1-5.
Zotero 插件